SCHEMBL6439243

SCHEMBL6439243

Cc1ccc2cc(C(=O)N(N)c3ccc(NC(=O)c4cnccn4)cc3)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 14/20 0.51
NPC1 O15118 12/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
KMT2A Q03164 5/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 3/20 0.47
USP2 O75604 2/20 0.47
TP53 P04637 2/20 0.47
POLB P06746 2/20 0.44
HPGD P15428 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6436343 0.81 NPC1 (0.56) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL6439246 0.75 RAB9A (0.56) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL3238075 0.74 MMP9 (0.56) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL19476630 0.71 NPC1 (0.71) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL27918347 0.71 RAB9A (0.63) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL18027795 0.70 NPC1 (1.00) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL26372752 0.69 NPC1 (0.69) RAB9ANPC1KMT2AMEN1POLB
SCHEMBL26372749 0.68 NPC1 (0.64) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7718028 0.67 NPC1 (0.72) RAB9ANPC1SMN1; SMN2KMT2AMAPT
SCHEMBL5553523 0.67 NPC1 (0.51) RAB9ANPC1SMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509516-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE Aventis Pharma Deutschland GmbH (DE) 2005-03-02 EP disclosed
WO-2003104221-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-18 WO disclosed